Media Summary: Biomarkers are mutations on cancer cells that we can test for and sometimes treat. How do we find them, how did they get there, ... Living with serious illness raises important questions about what matters most—to us and to the people who care about us. Cholangiocarcinoma, or bile duct cancer, can be challenging to manage. Join us to learn about a new, personalized approach ...
Ccf Webinar Understanding A Phase - Detailed Analysis & Overview
Biomarkers are mutations on cancer cells that we can test for and sometimes treat. How do we find them, how did they get there, ... Living with serious illness raises important questions about what matters most—to us and to the people who care about us. Cholangiocarcinoma, or bile duct cancer, can be challenging to manage. Join us to learn about a new, personalized approach ... We will explore the emerging role of histotripsy—a noninvasive, focused ultrasound therapy—in the management of patients with ... Learn from a surgeon and a patient about Hepatic Artery Infusion (HAI) therapy, including: - How HAI therapy fits in with other ... Join the Cholangiocarcinoma Foundation and Society of Interventional Oncology (SIO) for a compelling
One important piece of the puzzle in cholangiocarcinoma (CCA) research is We reviewed the side effects of FGFR inhibitors and the supportive care treatments to help manage them. Sponsored by Taiho ... Up to 20% of biliary tract cancer patients have peritoneal metastases, resulting in symptoms of ascites, abdominal pain, and ...
